Is Aarti Industries a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Industries Ltd is a good quality company .

Is Aarti Industries undervalued or overvalued?

The key valuation ratios of Aarti Industries Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Aarti Industries share price return in the past 10 years?

Aarti Industries Ltd share price has appreciated 19.2% annually (CAGR) over the past ten years.

Is Aarti Industries a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aarti Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Aarti Industries?

The latest standalone P/E ratio of Aarti Industries as of 21-Nov-2024 is 35.11.

What is the P/B ratio of Aarti Industries?

The latest standalone P/B ratio of Aarti Industries as of 21-Nov-2024 is 2.89.

What is the 52-week high and low of Aarti Industries?

The 52-week high of Aarti Industries is Rs. 769.50 and the 52-week low is Rs. 426.50.

Aarti Industries Ltd - Stock Valuation and Financial Performance

Name: Aarti Industries
Brand: Aarti Industries

BSE: 524208 | NSE: AARTIIND | Chemicals | Small Cap

Place order

Aarti Inds Share Price

₹425.65 -9.15 -2.10%
as on 21-Nov'24 16:59

10 Year X-Ray of Aarti Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	19%	20.7%	19.9%	17%	18.5%	15.9%	13.2%	22%	10.5%	7.5%	-
Value Creation Index ⓘ	0.4	0.5	0.5	0.3	0.4	0.2	0.2	1.0	-0.2	-0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2,908	3,007	3,163	3,806	4,168	4,186	4,506	6,086	6,619	6,372	6,988
Sales YoY Gr.	-	3.4%	5.2%	20.3%	9.5%	0.5%	7.6%	35.1%	8.8%	-3.7%	-
Adj EPS ⓘ	5.7	7.7	9.6	10.1	14.2	15.2	15	32.7	15	11.6	12.3
YoY Gr.	-	35.8%	24.7%	5.2%	40.1%	7.5%	-1.3%	117.7%	-54%	-23.1%	-
BVPS (₹) ⓘ	28.7	34.1	41.5	48.5	75.9	85.5	100.5	124.6	135.7	145.9	150.2
Adj Net Profit ⓘ	201	257	315	329	491	530	523	1,185	545	419	445
Cash Flow from Ops. ⓘ	340	574	470	335	736	1,102	873	519	1,319	1,204	-
Debt/CF from Ops. ⓘ	3.5	2.3	3.3	6.2	3.3	1.9	3.3	5	2.2	2.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	9.1%	8.9%	12.2%	-3.7%
Adj EPS ⓘ	8.3%	-4%	-8.3%	-23.1%
BVPSⓘ	19.8%	14%	13.2%	7.5%
Share Price	19.2%	0.2%	-24.1%	-18.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	21.3	23.8	25.2	22.3	23.3	18.9	16.1	29.6	11.6	8.2	8.3
Op. Profit Mgn % ⓘ	16	19	20.7	18.4	23.2	23.4	21.8	28.3	16.5	15.4	15
Net Profit Mgn % ⓘ	6.5	8.9	10.3	9	12.1	12.9	11.9	19.5	8.2	6.6	6.4
Debt to Equity ⓘ	1.2	1.1	1.2	1.3	0.9	0.7	0.8	0.6	0.6	0.6	0.3
Working Cap Days ⓘ	187	179	161	160	153	168	161	132	126	124	71
Cash Conv. Cycle ⓘ	74	81	80	83	80	90	75	64	82	79	-6

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 12.24%

Debt to equity has declined versus last 3 years average to 0.60

Sales growth is good in last 4 quarters at 13.52%

Return on Equity has declined versus last 3 years average to 8.30%

Net Profit has been subdued in last 3 years -8.33%

Latest Financials - Aarti Industries Ltd.

	Standalone	Consolidated
TTM EPS (₹)	12.4	12.3
TTM Sales (₹ Cr.)	7,057	6,988
BVPS (₹.) ⓘ	150.3	150.2
Reserves (₹ Cr.) ⓘ	5,269	5,262
P/BV ⓘ	2.89	2.90
PE ⓘ	35.11	35.42

From the Market
52 Week Low / High (₹)	426.50 / 769.50
All Time Low / High (₹)	0.64 / 1168.40
Market Cap (₹ Cr.)	15,762
Equity (₹ Cr.)	181.3
Face Value (₹)	5
Industry PE ⓘ	56.1

Management X-Ray of Aarti Inds:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

2.38

3.68

3.79

3.85

* Pledged shares as % of Promoter's holding (%)

Valuation of Aarti Inds

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Aarti Inds

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	2,908	3,007	3,163	3,806	4,168	4,186	4,506	6,086	6,619	6,372
Operating Expenses ⓘ	2,442	2,434	2,510	3,107	3,202	3,209	3,525	4,365	5,530	5,396
Manufacturing Costs	516	568	644	790	862	918	1,063	1,210	1,425	1,157
Material Costs	1,642	1,573	1,536	1,901	1,848	1,757	1,801	2,389	3,261	3,483
Employee Cost	94	121	152	190	243	305	371	357	385	404
Other Costs ⓘ	191	173	178	226	250	229	289	409	459	352
Operating Profit ⓘ	466	572	654	699	965	977	982	1,720	1,089	977
Operating Profit Margin (%)	16.0%	19.0%	20.7%	18.4%	23.2%	23.3%	21.8%	28.3%	16.5%	15.3%
Other Income ⓘ	6	6	2	8	2	9	1	1	1	8
Interest ⓘ	138	117	117	132	183	125	86	102	168	211
Depreciation ⓘ	82	99	123	146	163	185	231	246	310	378
Exceptional Items ⓘ	3	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	255	363	416	429	622	676	665	1,372	611	395
Tax ⓘ	61	95	88	83	118	129	129	186	66	-21
Profit After Tax	194	268	328	346	504	547	535	1,186	545	416
PAT Margin (%)	6.7%	8.9%	10.4%	9.1%	12.1%	13.1%	11.9%	19.5%	8.2%	6.5%
Adjusted EPS (₹)	5.8	7.7	9.6	10.2	14.2	15.4	15.0	32.7	15.0	11.5
Dividend Payout Ratio (%)	24%	28%	3%	2%	19%	11%	10%	11%	17%	9%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	1,016	1,137	1,362	1,578	2,631	2,979	3,503	4,516	4,920	5,287
Share Capital ⓘ	44	42	41	41	43	87	87	181	181	181
Reserves ⓘ	972	1,096	1,321	1,538	2,587	2,892	3,416	4,335	4,739	5,106
Minority Interest	6	52	64	77	84	95	12	1	1	1
Debt	1,067	1,233	1,436	1,921	2,106	1,811	2,492	2,208	2,520	2,714
Long Term Debt	419	527	596	908	815	581	1,268	930	635	1,524
Short Term Debt	648	706	839	1,012	1,291	1,230	1,224	1,278	1,885	1,191
Trade Payables	249	305	300	357	279	345	576	345	216	521
Others Liabilities ⓘ	599	239	337	458	759	1,103	1,058	753	872	948
Total Liabilities ⓘ	2,938	2,966	3,499	4,391	5,858	6,333	7,642	7,823	8,528	9,472
Fixed Assets
Gross Block	1,685	2,081	2,655	3,101	3,362	3,837	5,155	5,005	6,306	7,292
Accumulated Depreciation	718	835	958	1,103	1,215	1,369	1,563	1,410	1,445	1,643
Net Fixed Assetsⓘ	967	1,246	1,697	1,998	2,147	2,468	3,593	3,595	4,861	5,649
CWIP ⓘ	193	313	270	436	795	1,418	1,298	1,346	1,096	1,229
Investmentsⓘ	139	41	47	47	33	37	64	28	17	23
Inventories	552	495	571	747	772	836	936	934	1,031	1,160
Trade Receivables	439	523	525	655	776	753	794	1,092	940	826
Cash Equivalents	34	29	29	32	804	247	412	174	201	130
Others Assetsⓘ	614	319	361	476	532	573	546	655	382	455
Total Assets ⓘ	2,938	2,966	3,499	4,391	5,858	6,333	7,642	7,823	8,528	9,472

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	340	574	470	335	736	1,102	873	519	1,319	1,204
PBT ⓘ	251	363	416	429	622	676	665	1,372	611	395
Adjustment ⓘ	215	212	239	268	344	300	312	348	478	593
Changes in Working Capital ⓘ	-69	96	-87	-263	-99	290	-7	-955	321	306
Tax Paid ⓘ	-58	-98	-97	-99	-131	-164	-97	-246	-91	-91
Cash Flow From Investing Activity ⓘ	-298	-452	-529	-610	-797	-1,124	-1,322	-1,169	-1,330	-1,310
Capex	-295	-450	-530	-614	-791	-1,126	-1,314	-1,165	-1,326	-1,304
Net Investments	-4	-4	1	3	-6	-3	-8	-5	-4	-6
Others ⓘ	1	2	0	0	0	4	0	1	0	0
Cash Flow From Financing Activityⓘ	-23	-128	58	279	833	-535	614	412	38	35
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	1,187	0	0
Net Proceeds from Borrowing ⓘ	202	31	139	346	40	-242	752	-595	-301	889
Interest Paid ⓘ	-138	-117	-117	-132	-183	-125	-86	-102	-168	-211
Dividend Paid ⓘ	-48	-95	-1	-10	-44	-106	-45	-127	-91	-54
Others ⓘ	-39	53	37	75	1,020	-62	-6	49	598	-589
Net Cash Flow ⓘ	19	-7	0	4	772	-557	165	-239	27	-71

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	20.54	24.91	26.22	23.55	23.96	19.5	16.52	29.58	11.56	8.16
ROCE (%)	19.03	20.65	19.91	17.02	18.51	15.85	13.15	21.96	10.48	7.46
Asset Turnover Ratio	1.11	1.02	0.98	0.96	0.92	0.76	0.72	0.89	0.89	0.78
PAT to CFO Conversion(x)	1.75	2.14	1.43	0.97	1.46	2.01	1.63	0.44	2.42	2.89
Working Capital Days
Receivable Days	52	58	60	57	55	60	56	50	51	46
Inventory Days	68	64	62	63	59	63	64	50	49	57
Payable Days	69	64	72	63	63	65	93	70	31	39

Aarti Industries Ltd Stock News

Aarti Industries Ltd FAQs

What is the share price of Aarti Inds?

Company share prices are keep on changing according to the market conditions. The closing price of Aarti Inds on 21-Nov-2024 16:59 is ₹425.6.

What is the market cap of Aarti Inds?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Aarti Inds stood at ₹15,762.3.

What is the P/E ratio of Aarti Inds?

The latest P/E ratio of Aarti Inds as of 21-Nov-2024 16:59 is 35.11.

What is the P/B ratio of Aarti Inds?

The latest P/B ratio of Aarti Inds as of 21-Nov-2024 16:59 is 2.89.

What is the 52-week high and low of Aarti Inds?

The 52-week high of Aarti Inds is ₹769.5 and the 52-week low is ₹426.5.

What is the TTM revenue of Aarti Inds?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarti Inds is ₹7,057 ( Cr.) .

About Aarti Industries Ltd

Aarti Industries Limited is listed entity incorporated in India. Aarti Industries is a leading Indian manufacturer of Speciality Chemicals and Pharmaceuticals with a global footprint. Chemicals manufactured by the company are used in the downstream manufacture of pharmaceuticals, agrochemicals, polymers, additives, surfactants, pigments, dyes, etc.

Business area of the company

Aarti Industries is engaged in manufacturing and dealing in speciality chemicals and pharmaceuticals.

Products offered by the company

Chemical products

Chlorination
Nitration
Hydrogenation
Ammonolysis
Halex
Dinitro chlorination
Alkylation
Hydrolysis
Methoxylation
Esterification
Diazaotiation
Sulphonation
Condensation
N-Alkylation
Oxidation
Other (inorganic)

Pharma

Anti Hypertensive

Ramipril
Quinapril HCL
Benazepril HCL
Benazepril HCL Polymorph B
Perindopril Tert-butylamine
Perindopril Arginine
Ranolazine Di-HCL / Base

Anti Asthamatic

Budesonide
Bambuterol HCL
Salmeterol Xinafoate
Ipratropium Bromide
Ciclesonide
Fluticasone Propionate
Fluticasone Furoate
Mometasone Furoate Monohydrate
Formoterol Fumarate
Montelukast Sodium

Anti Cancer

Bicalutamide
Ifosfamide
Ifosfamide Sterile
Cyclophosphamide
Cyclophosphamide Sterile
Mesna
Mercaptopurine
Azathioprine
Capecitabine
R-Salbutamol Sulphate
Levalbuterol HCL
Levalbuterol Tartrate

Milestones

1984

Incorporated Aarti Organics Private Limited.

1986

Commenced 1,200 Tonnes Per Annum (TPA) unit for Nitro Chloro Benzenes (NCB) in Sarigram, Gujarat.

1990

Set up the first large-scale organic plant in Vapi - 4,500 TPA unit for NCB.

2001

Set up a large-scale hydrogenation and nitration unit at Jhagadia (hydrogen gas via pipeline).

2005-08

Expanded the NCB and sulphuric acid capacity.
Set up a large-scale speciality chemical unit in Kutch.
Received US FDA approval for an Active Pharmaceutical Ingredient (API) unit in Tarapur.

2011

Upgraded the hydrogenation unit from batch to continuous.
Received USFDA approval for the custom synthesis division at Vapi.
Commenced bulk shipment for global markets.

2016

Commissioned an ethylation facility at Dahej SEZ (ethylene gas via pipeline).
Expanded the NCB capacity from 57 KTPA to 75 KTPA.

2017

Commenced the functioning of the calcium chloride facility.
Started operations at co-generation and solar power plants.

2018

Commissioned the Nitro Toulene plant.
Signed two large multi-year contracts with global players.
Manufacturing facility being set up at Dahej SEZ.

2019

Commissioned the Nitro Toulene hydrogenation facility at Jhagadia.
Signed another multi-year contract with a global player.

2020

Operationalised Aarti Research and Technology Centre (ARTC) at Mahape, Navi Mumbai.
Commissioned two units at Dahej SEZ for high-value speciality chemicals.